AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About LNSR20261016C7.5
Medical instruments
Incorporated in Delaware on August 20, 2004, Lensar, Inc., is a commercial-stage medical device company specializing in the design, development and marketing of advanced laser systems for cataract treatment and corneal astigmatism management. The company's laser systems incorporate a number of proprietary technologies, providing advanced imaging capabilities, simplified surgical planning, efficient design and precise operation. The ALLY system, which received regulatory approval in 2022, integrates these functions into a compact platform designed to support aseptic cataract surgery in a single operating room. The company has offered its system to cataract surgeons in the US, EU and several other markets.
